Barclays’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.3M Buy
933,512
+544,674
+140% +$23.5M 0.01% 594
2025
Q1
$13.4M Sell
388,838
-58,672
-13% -$2.03M ﹤0.01% 874
2024
Q4
$12.3M Sell
447,510
-97,498
-18% -$2.68M ﹤0.01% 1005
2024
Q3
$13.9M Buy
545,008
+131,743
+32% +$3.35M ﹤0.01% 874
2024
Q2
$10.5M Buy
413,265
+8,097
+2% +$205K ﹤0.01% 887
2024
Q1
$12.5M Sell
405,168
-336,870
-45% -$10.4M ﹤0.01% 911
2023
Q4
$30M Buy
742,038
+260,598
+54% +$10.5M 0.01% 640
2023
Q3
$12.7M Sell
481,440
-107,724
-18% -$2.84M 0.01% 796
2023
Q2
$10.1M Sell
589,164
-81,715
-12% -$1.41M 0.01% 903
2023
Q1
$11.1M Sell
670,879
-531,006
-44% -$8.8M 0.01% 773
2022
Q4
$9.16M Buy
1,201,885
+875,468
+268% +$6.67M ﹤0.01% 859
2022
Q3
$3.24M Buy
326,417
+296,979
+1,009% +$2.95M ﹤0.01% 1344
2022
Q2
$268K Sell
29,438
-13,148
-31% -$120K ﹤0.01% 2977
2022
Q1
$432K Sell
42,586
-151,488
-78% -$1.54M ﹤0.01% 2896
2021
Q4
$3.24M Buy
194,074
+104,508
+117% +$1.74M ﹤0.01% 1510
2021
Q3
$4.2M Buy
89,566
+26,546
+42% +$1.24M ﹤0.01% 1344
2021
Q2
$3.84M Sell
63,020
-37,199
-37% -$2.27M ﹤0.01% 1343
2021
Q1
$6.17M Buy
100,219
+63,771
+175% +$3.93M ﹤0.01% 1052
2020
Q4
$2.59M Buy
36,448
+3,076
+9% +$219K ﹤0.01% 1424
2020
Q3
$1.25M Sell
33,372
-12,116
-27% -$455K ﹤0.01% 1784
2020
Q2
$1.48M Buy
45,488
+16,124
+55% +$526K ﹤0.01% 1671
2020
Q1
$851K Buy
29,364
+3,230
+12% +$93.6K ﹤0.01% 1830
2019
Q4
$916K Buy
26,134
+12,431
+91% +$436K ﹤0.01% 2350
2019
Q3
$294K Sell
13,703
-3,631
-21% -$77.9K ﹤0.01% 2882
2019
Q2
$467K Buy
+17,334
New +$467K ﹤0.01% 2749